Diabetes Hospital and Research Centre
Peshawar, Khyber Pakhtunkhwa, 25100, Pakistan
NCT Number: NCT07030543
This study aims to test whether a personalized meal plan (Individualized Dietary Plan, IDP) is practical and helpful for adults with type 2 diabetes in Peshawar, Pakistan. We want to see if patients can follow the IDP for 10 weeks and if it improves their blood sugar control and cholesterol levels. About 122 participants will be randomly assigned to either the IDP group (receiving customized diet advice) or a standard care group. We will measure their weight, blood sugar (HbA1c), cholesterol, and other health markers at the start and after 3 months. Results will show if a larger study is feasible in our local community.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Peshawar, Khyber Pakhtunkhwa, 25100, Pakistan
Type 2 diabetes prevalence in Pakistan is high (16.98%), yet standardized dietary advice is often given without considering individual factors like age, weight, or lifestyle. Evidence shows nutrition therapy improves glycemic control, but no studies have tested personalized dietary plans in Pakistan's local population. This feasibility trial addresses this gap by evaluating the practicality of implementing IDPs at the Diabetes Hospital and Research Centre Peshawar.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study evaluates the feasibility of an Individualized Dietary Plan (IDP), a structured, patient-tailored nutrition intervention designed to improve glycemic control and lipid profiles in adults with Type 2 Diabetes Mellitus (T2DM).
Other names: Personalized Nutrition Therapy, Medical Nutrition Therapy (MNT), Diabetes-Specific Meal Plan
Standard dietary advice as per the current clinical practice.
Time frame: Baseline to 3 months.
Measures participant adherence to the IDP using the Perceived Dietary Adherence Questionnaire (PDAQ).
The scoring of the questionnaire are as follows:
Good Adherence: Score ≥70 (consistent adherence over 10 weeks).
Poor Adherence: Score 45-69 (inconsistent adherence over 7-9 weeks).
Time frame: Enrollment to study completion (6 months)
Assesses acceptability via recruitment rate, calculated as:
Formula: (Number of participants completing 3 month follow-up) ÷ (Number of randomized participants) × 100.
Time frame: Baseline to 3 months
Measures difference in HbA1c levels (reflecting 3-month average blood glucose) between IDP and control groups.
The threshold of glycemic control are as follows:
Normal: <7%. Abnormal: ≥7%.
Khyber Medical University Peshawar
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsNCT05313529
Cognition Disorders, Cognitive Dysfunction
Changzhou, Jiangsu, China
View Trial DetailsNCT05684341
Diabetes Mellitus, Diabetes Mellitus, Type 2
Changhua, Taiwan
View Trial DetailsNCT07255820
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus
Karachi, Sindh, Pakistan
View Trial Details